Stock Analysis
ALNY
Alnylam Pharmaceuticals, Inc. · Healthcare
Win Score
70
Risk Score
30
Score History
Last 12 monthsIn context
Its Win Score ranks above 95% of the 117 analysed Healthcare stocks in the same sector. The average Win Score in this sector is 50. Its Risk Score is more favourable than 97% of sector peers – a lower value is better.
More stocks in Healthcare
AMGNAmgen Inc.ARWRArrowhead Pharmaceuticals, Inc.ATRAptarGroup, Inc.AVTRAvantor, Inc.AZN.LAstraZeneca PLCBAXBaxter International Inc.BAYN.DEBayer AktiengesellschaftBDXBecton, Dickinson and CompanyBIIBBiogen Inc.BIOBio-Rad Laboratories, Inc.BMRNBioMarin Pharmaceutical Inc.BMYBristol-Myers Squibb Company
All metrics and scores are for informational purposes only, identical for every user, and do not constitute investment advice or a recommendation to buy or sell.
Unlock the full analysis
Fundamentals, sector comparison, watchlist, and alerts for every scanned stock – sign up for free.
Sign up for free →